Auner, H. W., Iacobelli, S., Sbianchi, G., Knol-Bout, C., Blaise, D., Russell, N. H., Apperley, J. F., Pohlreich, D., Browne, P. V., Kobbe, G., Isaksson, C., Lenhoff, S., Scheid, C., Touzeau, C., Jantunen, E., Anagnostopoulos, A., Yakoub-Agha, I., Tanase, A., Schaap, N., Wiktor-Jedrzejczak, W., Krejci, M., Schönland, S. O., Morris, C., Garderet, L. and Kröger, N. (2018) “Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party”, Haematologica. Pavia, Italy, 103(3), pp. 514-521. doi: 10.3324/haematol.2017.181339.